Bausch Health director granted 45,871 RSUs

ROBERTS EIRY reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

ROBERTS EIRY reported acquisition or exercise transactions in this Form 4 filing.

Bausch Health Companies Inc. director Eiry Roberts received a compensation-related equity grant. On May 22, 2026, she was awarded 45,871 restricted share units (RSUs), which will be settled in common shares at no purchase price. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the company’s next annual meeting of shareholders, and are intended for non-employee directors. Following this grant, Roberts holds 45,871 common shares directly, showing this is an initial or refreshed equity position rather than an open-market purchase or sale.

Insights

Equity compensation analyst

Routine director RSU grant, no open-market trading.

Non-employee director Eiry Roberts received 45,871 RSUs in Bausch Health Companies Inc. with a grant date value of $250,000. The award vests before the next annual shareholder meeting and settles in common shares at no purchase cost.

This is a standard board compensation structure, classified as an acquisition under transaction code A rather than a market buy. There are no derivative holdings reported and no sales or tax-withholding dispositions, so the filing mainly documents equity-based pay rather than a signaling trade.

Insider Trade Summary

Grant/Award: 45,871 shares

Grant/Award 1 txn

Insider ROBERTS EIRY

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	45,871	$0.00	$0.00

Holdings After Transaction: Common Shares, No Par Value — 45,871 shares (Direct)

Footnotes (1)

1. F1. Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Key Figures

RSUs granted: 45,871 units Grant date value: $250,000 Price per share: $0.00 +1 more

4 metrics

RSUs granted 45,871 units Restricted share units awarded to director on May 22, 2026

Grant date value $250,000 Value of RSU award to non-employee directors

Price per share $0.00 No purchase price; compensation grant, not market buy

Shares held after 45,871 shares Total Bausch Health common shares held directly after grant

Key Terms

restricted share units ("RSUs"), grant date value, non-employee directors, Annual Meeting of Shareholders

4 terms

restricted share units ("RSUs") financial

"Represents the award of restricted share units ("RSUs") granted to non-employee directors"

grant date value financial

"The RSUs have a grant date value of $250,000, vest on the date"

non-employee directors financial

"RSUs granted to non-employee directors of the Issuer on the third business day"

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

Annual Meeting of Shareholders regulatory

"their election at the Issuer's Annual Meeting of Shareholders. The RSUs have"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bausch Health (BHC) director Eiry Roberts receive in this Form 4?

Director Eiry Roberts received a grant of 45,871 restricted share units from Bausch Health. The RSUs are a non-cash equity award for non-employee directors, with a grant date value of $250,000, and will be settled in common shares at no purchase price.

How many Bausch Health shares does Eiry Roberts hold after this transaction?

After the RSU grant, Eiry Roberts beneficially holds 45,871 Bausch Health common shares. This reflects the full amount from the May 22, 2026 award, with no reported prior holdings or additional derivative positions in this filing for further context.

Was the Bausch Health Form 4 for Eiry Roberts a stock purchase or sale?

The Form 4 reports an acquisition coded as a grant, not a market trade. Roberts received 45,871 restricted share units as director compensation. No open-market purchases, sales, or tax-related share dispositions are reported in this filing for Bausch Health Companies Inc.

What are the vesting terms of Eiry Roberts’ Bausch Health RSU award?

The RSUs granted to Eiry Roberts vest on the date immediately preceding Bausch Health’s next annual meeting. Once vested, they will be settled in the company’s common shares, aligning director compensation with shareholder interests over the board service period.

What is the dollar value of the Bausch Health RSU grant to Eiry Roberts?

The restricted share unit award to Eiry Roberts has a grant date value of $250,000. This value reflects the standard annual equity compensation for non-employee directors and is paid entirely in RSUs that will convert into common shares when they vest.

Does the Form 4 for Bausch Health show any derivatives or options for Eiry Roberts?

The filing shows no derivative securities or options positions for Eiry Roberts. It only reports the grant of 45,871 restricted share units, which will be settled in Bausch Health common shares, and lists no remaining derivative holdings after this transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 07:02 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROBERTS EIRY

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	05/22/2026		A		45,871(1)	A	$0	45,871	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

	/s/ Brianna M. Dorsi, attorney-in-fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)